The head of India’s Covid-19 task force, VK Paul on Thursday while releasing a statement on “myths and facts on India’s vaccination progress” said that as soon as Pfizer indicated availability, the central government and the US pharma major started working together for the earliest possible import of the vaccine.
Pfizer, which is ready to offer 5 crore doses to India between July and October this year, has resportedly sought certain relaxations from the government including indemnification.
Paul pointed out that vaccines are in limited supply globally, and companies have their own priorities, game-plans and compulsions in allocating finite stocks as he dismissed the notion that the government isn’t doing enough to purchase vaccines from abroad.